Comment
doi: 10.1016/j.maturitas.2007.04.002.
Epub 2007 May 25.
Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years
- PMID: 17532152
- DOI: 10.1016/j.maturitas.2007.04.002
Item in Clipboard
Comment
Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years
Maturitas.
.
No abstract available
Comment on
-
Benefits and risks of long-term low-dose oral continuous combined hormone therapy.Maturitas. 2007 Mar 20;56(3):231-48. doi: 10.1016/j.maturitas.2006.08.004. Epub 2006 Oct 10. Maturitas. 2007. PMID: 17034966 Review.
Similar articles
-
Benefits and risks of long-term low-dose oral continuous combined hormone therapy.Maturitas. 2007 Mar 20;56(3):231-48. doi: 10.1016/j.maturitas.2006.08.004. Epub 2006 Oct 10. Maturitas. 2007. PMID: 17034966 Review.
-
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.Adv Ther. 2008 Jun;25(6):525-51. doi: 10.1007/s12325-008-0070-6. Adv Ther. 2008. PMID: 18568306 Review.
-
Oral contraceptives, menopause hormone replacement therapy, and risk of stroke.Maturitas. 2004 Apr 15;47(4):265-8. doi: 10.1016/j.maturitas.2003.11.008. Maturitas. 2004. PMID: 15063478 Review.
-
Menopause and stroke and the effects of hormonal therapy.Climacteric. 2007 Oct;10 Suppl 2:27-31. doi: 10.1080/13697130701550903. Climacteric. 2007. PMID: 17882669 Review.
-
Estrogen and stroke: a case for low-dose estrogen.Menopause. 2006 Sep-Oct;13(5):719-20. doi: 10.1097/01.gme.0000232280.89842.d0. Menopause. 2006. PMID: 16932238 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
